US FDA bans 23andme direct to consumer genetic testing kit
FDA Orders Genetic Testing Firm 23andme to Stop Marketing DNA Analysis Service — Blocks Sale of a Company’s Mail-Order Gene Tests – The Food and Drug Administration, USA has ordered 23andme – the maker of a popular genetic-testing kit to stop sales of its heavily marketed product, saying the mail-order tests haven’t been proven effective and could dangerously mislead people about their health.